Gbadegesin et al. identified a missense mutation in ANLN as a cause of focal segmental glomerulosclerosis (FSGS) and found the mutant ANLN displayed reduced binding to the scaffold protein CD2AP (Gbadegesin et al., 2014). The gene discussed is ANLN; the disease is focal segmental glomerulosclerosis.